BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES - A STUDY IN HEALTHY-SUBJECTS

被引：18

作者：

GUTIERREZ, A ^{[1
]}

ALVESTRAND, A ^{[1
]}

BERGSTROM, J ^{[1
]}

BEVING, H ^{[1
]}

LANTZ, B ^{[1
]}

HENDERSON, LW ^{[1
]}

机构：

[1] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT RENAL MED,S-14186 HUDDINGE,SWEDEN

来源：

BLOOD PURIFICATION | 1994年 / 12卷 / 02期

关键词：

HEMODIALYSIS; BIOCOMPATIBILITY; COMPLEMENT ACTIVATION; ELASTASE;

D O I：

10.1159/000170153

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The effect of blood-membrane interaction on several biocompatibility parameters has been investigated. Four groups of healthy subjects underwent sham hemodialysis, i.e. the establishment of blood-dialysis membrane contact, but without circulating dialysate, using cellulose-based membranes (regenerated cellulose and cellulose acetate) or synthetic membranes (polysulfone and polyacrilonitrile). Contact between blood and cellulose-based membranes resulted in pronounced complement activation and leukopenia whereas contact between blood and synthetic membranes induced weak complement reaction. The release of granulocytic elastase comparable to that obtained during clinical dialysis seemed to correlate directly with the types of membrane used. The gradual increase in the level of plasma elastase during blood-membrane contact, as opposed to the transient nature of the increase in the levels of complement, suggests that different mechanisms are responsible for these reactions. Nutritional implications of dialysis membrane bioincompatibility are discussed in the light of recently published metabolic data obtained in these subjects.

引用

页码：95 / 105

页数：11

共 35 条

[1]

Craddock P.R., Fehr J., Brigham K.L., Kronenberg R.S., Jacob H.S., Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis, N Engl J Med, 296, pp. 760-774, (1977)

[2]

Craddock P.R., Hammerschmidt D.E., White J.G., Dalmasso A.P., Jacob H.S., Complement (C5a)-induced granulocyte aggregation in vitro: A possible mechanism of comple- ment-mediatcd leukostasis and leukopenia, J Clin Invest, 60, pp. 260-264, (1977)

[3]

Henderson L.W., Chenoweth D., Biocompatibility of artificial organs: An overview, Blood Purif, 5, pp. 100-111, (1987)

[4]

Bergstrom J., Protein catabolic factors in patients on renal replacement therapy, Blood Purif, 3, pp. 215-236, (1985)

[5]

De Broc M.E., Clinical significance of bioincompatibility in hemodialysis, Contrib Nephrol, 62, pp. 35-43, (1988)

[6]

Gutierrez A., Alvestrand A., Wahren J., Bergstrom J., Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans, Kidney Int, 38, pp. 487-494, (1990)

[7]

Borah M.F., Schoenfeld P.Y., Gotch F.A., Sargent J.A., Wolfson M., Humphreys M.H., Nitrogen balance during intermittent dialysis therapy of uremia, Kidney Int, 14, pp. 491-500, (1978)

[8]

Farrell P.C., Hone P.W., Dialysis-induced catabolism, Am J Clin Nutr, 33, pp. 1417-1422, (1980)

[9]

Chenoweth D.E., Cheung A.K., Henderson L.W., Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes, Kidney Int, 24, pp. 764-769, (1983)

[10]

Horl W.H., Jochum M., Heidland A., Fritz H., Release of granulocyte pro- teinases, Am J Nephrol, 3, pp. 213-217, (1983)

← 1 2 3 4 →